Publicacions en col·laboració amb investigadors/es de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (8)

2024

  1. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

    United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068

2022

  1. Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr−/−.Leiden mice without attenuation of steatohepatitis

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Dietary Approach to NAFLD

    Non-Alcoholic Fatty Liver Disease: A 360-degree Overview (Springer International Publishing), pp. 271-287

  2. Geometry of nutrition: Nutrients and NAFLD progression

    NAFLD and NASH: Biomarkers in Detection, Diagnosis and Monitoring (Springer International Publishing), pp. 49-67

2019

  1. Extra virgin olive oil diet intervention improves insulin resistance and islet performance in diet-induced diabetes in mice

    Scientific Reports, Vol. 9, Núm. 1

  2. Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models

    Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 301-307

2018

  1. Extra-Virgin Olive Oil with Natural Phenolic Content Exerts an Anti-Inflammatory Effect in Adipose Tissue and Attenuates the Severity of Atherosclerotic Lesions in Ldlr−/−.Leiden Mice

    Molecular Nutrition and Food Research, Vol. 62, Núm. 13